A. Falck

发表

Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer

M. Fernö, P. Bendahl, L. Rydén, 2018, BMC Cancer.

The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence

K. Pietras, P. Bendahl, Kristina Aaltonen, 2018, Breast Cancer Research and Treatment.

Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study

M. Fernö, J. Isola, K. Lövgren, 2012, BMC Cancer.

Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression

M. Fernö, K. Lövgren, P. Bendahl, 2020, Breast Cancer Research and Treatment.

The Three Receptor Tyrosine Kinases c-KIT, VEGFR2 and PDGFRα, Closely Spaced at 4q12, Show Increased Protein Expression in Triple-Negative Breast Cancer

M. Fernö, P. Bendahl, Kristina Aaltonen, 2014, PloS one.

Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years’ follow-up

M. Fernö, P. Bendahl, L. Rydén, 2013, Breast Cancer Research and Treatment.

Modern Staging in Primary Breast Cancer-aspects of micrometastatic disease in bone marrow and molecular profiles in lymph node metastases

A. Falck, Anna-Karin Falck, 2013 .

The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer

M. Fernö, I. Hedenfalk, K. Jirström, 2013, SpringerPlus.

Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013

M. Fernö, C. Elston, A. Ehinger, 2017, Acta oncologica.

St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases - aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial

M. Fernö, P. Bendahl, L. Rydén, 2013, BMC Cancer.

Gallen molecular subtypes in primary breast cancer and matched lymph node metastases-aspects on distribution and prognosis for patients with luminal A tumours : results from a prospective randomised trial

M. Fernö, P. Bendahl, L. Rydén, 2013 .

St Gallen molecular subtypes in screening‐detected and symptomatic breast cancer in a prospective cohort with long‐term follow‐up

M. Fernö, H. Olsson, P. Bendahl, 2016, The British journal of surgery.

Does Analysis of Biomarkers in Tumor Cells in Lymph Node Metastases Give Additional Prognostic Information in Primary Breast Cancer?

M. Fernö, P. Bendahl, L. Rydén, 2010, World Journal of Surgery.